146 related articles for article (PubMed ID: 16564192)
1. The effect of treatment with moxifloxacin or azithromycin on acute bacterial rhinosinusitis in mice.
Luxameechanporn T; Blair C; Kirtsreesakul V; Thompson K; Naclerio RM
Int J Infect Dis; 2006 Sep; 10(5):401-6. PubMed ID: 16564192
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of importance of Toll-like receptor 4 in acute Streptococcus pneumoniae sinusitis in mice.
Luxameechanporn T; Kirtsreesakul V; Klemens J; Khoury P; Thompson K; Naclerio RM
Arch Otolaryngol Head Neck Surg; 2005 Nov; 131(11):1001-6. PubMed ID: 16301373
[TBL] [Abstract][Full Text] [Related]
3. Effect of topical ciprofloxacin/dexamethasone or dexamethasone alone on acute Streptococcus pneumoniae rhinosinusitis in mice.
Sahin-Yilmaz A; Baroody F; Markaryan A; Thompson K; Wall GM; Naclerio R
Otolaryngol Head Neck Surg; 2008 Mar; 138(3):340-6. PubMed ID: 18312882
[TBL] [Abstract][Full Text] [Related]
4. Persistent inflammation and hyperresponsiveness following viral rhinosinusitis.
Klemens JJ; Thompson K; Langerman A; Naclerio RM
Laryngoscope; 2006 Jul; 116(7):1236-40. PubMed ID: 16826067
[TBL] [Abstract][Full Text] [Related]
5. Bactrim reduces the inflammatory response in a murine model of acute rhinosinusitis.
Won YS; Brichta A; Baroody F; Boonlayangoor S; Naclerio R
Rhinology; 2000 Jun; 38(2):68-71. PubMed ID: 10953844
[TBL] [Abstract][Full Text] [Related]
6. Effect of montelukast on bacterial sinusitis in allergic mice.
Khoury P; Baroody FM; Klemens JJ; Thompson K; Naclerio RM
Ann Allergy Asthma Immunol; 2006 Sep; 97(3):329-35. PubMed ID: 17042138
[TBL] [Abstract][Full Text] [Related]
7. [A comparative experimental study between recombinant active gene 1-deficient mice and C57BL/6 mice model of acute bacterial rhinosinusitis].
Xie M
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Feb; 37(1):23-6. PubMed ID: 12768789
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
Zervos M; Martinez FJ; Amsden GW; Rothermel CD; Treadway G
Int J Antimicrob Agents; 2007 Jan; 29(1):56-61. PubMed ID: 17189096
[TBL] [Abstract][Full Text] [Related]
9. Moxifloxacin versus levofloxacin for treatment of acute rhinosinusitis: a retrospective database analysis of treatment duration, outcomes, and charges.
Keating KN; Friedman HS; Perfetto EM
Curr Med Res Opin; 2006 Feb; 22(2):327-33. PubMed ID: 16466604
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal activity of moxifloxacin against multidrug-resistant Streptoccocus pneumoniae at clinically achievable serum and epithelial lining fluid concentrations compared with three other antimicrobials.
Cafini F; Alou L; Sevillano D; Valero E; Prieto J;
Int J Antimicrob Agents; 2004 Oct; 24(4):334-8. PubMed ID: 15380257
[TBL] [Abstract][Full Text] [Related]
11. A pharmacodynamic approach to antimicrobial activity in serum and epithelial lining fluid against in vivo-selected Streptococcus pneumoniae mutants and association with clinical failure in pneumonia.
Alou L; Giménez MJ; Sevillano D; Aguilar L; Cafini F; Echeverría O; Pérez-Trallero E; Prieto J
J Antimicrob Chemother; 2006 Aug; 58(2):349-58. PubMed ID: 16782744
[TBL] [Abstract][Full Text] [Related]
12. Azithromycin modulates murine immune responses to pneumococcal conjugate vaccine and inhibits nasal clearance of bacteria.
Fernandez AD; Elmore MK; Metzger DW
J Infect Dis; 2004 Nov; 190(10):1762-6. PubMed ID: 15499531
[TBL] [Abstract][Full Text] [Related]
13. Correlation between in vitro and in vivo activity of levofloxacin and moxifloxacin against pneumococcal strains with different susceptibilities to fluoroquinolones.
Huelves L; Sevillano D; Martínez-Marín C; López-Casla MT; Gracia M; Alou L; del Carmen Ponte M; Prieto J; Soriano F;
Int J Antimicrob Agents; 2006 Apr; 27(4):294-9. PubMed ID: 16527462
[TBL] [Abstract][Full Text] [Related]
14. Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial.
Marple BF; Roberts CS; de Caprariis PJ; Reisman A
Clin Ther; 2007 Dec; 29(12):2690-8. PubMed ID: 18201585
[TBL] [Abstract][Full Text] [Related]
15. Sinus fluid penetration of oral clarithromycin and azithromycin in patients with acute rhinosinusitis.
Margaritis VK; Ismailos GS; Naxakis SS; Mastronikolis NS; Goumas PD
Am J Rhinol; 2007; 21(5):574-8. PubMed ID: 17999793
[TBL] [Abstract][Full Text] [Related]
16. Moxifloxacin and azithromycin but not amoxicillin protect human respiratory epithelial cells against streptococcus pneumoniae in vitro when administered up to 6 hours after challenge.
Ulrich M; Albers C; Möller JG; Dalhoff A; Korfmann G; Künkele F; Döring G
Antimicrob Agents Chemother; 2005 Dec; 49(12):5119-22. PubMed ID: 16304181
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
Odenholt I; Cars O
J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
[TBL] [Abstract][Full Text] [Related]
18. Acute bacterial rhinosinusitis in adults: part II. Treatment.
Scheid DC; Hamm RM
Am Fam Physician; 2004 Nov; 70(9):1697-704. PubMed ID: 15554487
[TBL] [Abstract][Full Text] [Related]
19. Effect of genetic background on the response to bacterial sinusitis in mice.
Kirtsreesakul V; Luxameechanporn T; Klemens JJ; Thompson K; Naclerio RM
Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1102-8. PubMed ID: 17043259
[TBL] [Abstract][Full Text] [Related]
20. In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains.
Rodríguez-Cerrato V; García P; Del Prado G; García E; Gracia M; Huelves L; Ponte C; López R; Soriano F
J Antimicrob Chemother; 2007 Nov; 60(5):1159-62. PubMed ID: 17827138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
